Breaking News

Neuro firm’s ALS drug gets FDA date; IPO might come first

Not rendering correctly? View this email as a web page here.

Cell therapy, AI drug discovery highlight 2021's record year in biotech IPOs

By Frank Vinluan Wednesday, December 29, 2021 4:58 PM

The biggest biotech IPO of 2021 belongs to a cell therapy developer that has yet to reach the clinic. Cell therapy and artificial intelligence were hot categories of newly public companies, but even though IPOs reached record levels this year that streak is not expected to continue in 2022.

Read more »

When it comes to breast cancer, the right data & outreach strategy impacts lives

By Mike Linnert and Ryan Younger Wednesday, December 29, 2021 2:00 PM

As health systems play catch up with backlogged – and potentially life-saving – screenings, it's important they prioritize people at higher risk, to ensure they have access to the preventive care they need.

Read more »

Delivering accessible vaccine and Covid-19 resources for children and families

By Sandhya Gardner Wednesday, December 29, 2021 8:15 AM

As new information around vaccines and children continues to evolve and surface,  maintaining a single point of entry for this information, that is updated in a timely fashion, can be incredibly helpful to caregivers.

Read more »

   

No comments